Fortune logo
ABC News logo
Associated Press logo
6 articles
·3M

All 50 States Reach $7.4 Billion Settlement with Purdue Pharma Over Opioid Crisis

All 50 U.S. states have agreed to a $7.4 billion settlement with Purdue Pharma to address the opioid crisis, funding addiction treatment and prevention programs.

Subscribe to unlock this story

We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!

Get Started

Have an account? Sign in

Overview

A summary of the key points of this story verified across multiple sources.

  • All 50 U.S. states, Washington, D.C., and four territories have agreed to a $7.4 billion settlement with Purdue Pharma over opioid-related lawsuits.
  • The Sackler family, owners of Purdue Pharma, will contribute up to $7 billion over 15 years as part of the settlement agreement.
  • A judge is being requested to advance the settlement to allow local governments and victims to vote on it after state support.
  • The settlement aims to allocate funds to state and local governments to combat the addiction and overdose crisis in the U.S.
  • This settlement represents one of the largest in a decade, reflecting a unified effort to address the opioid epidemic.
Written by AI using shared reports from
6 articles
.

Report issue

Pano Newsletter

Read both sides in 5 minutes each day

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Emphasizes all 50 U.S. states' support for Purdue Pharma's $7 billion opioid settlement plan.

"If approved, the settlement would be among the largest in a wave of lawsuits over the past decade as governments and others sought to hold drugmakers, wholesalers and pharmacies accountable for the opioid epidemic that started rising in the years after OxyContin hit the market in 1996."

FortuneFortune
·3M
Limited access — this outlet restricts by article count and/or content type.
Article

"If approved, the settlement would be among the largest in a wave of lawsuits over the past decade as governments and others sought to hold drugmakers, wholesalers and pharmacies accountable for the opioid epidemic that started rising in the years after OxyContin hit the market in 1996."

ABC NewsABC News
·3M
Article

"If approved, the settlement would be among the largest in a wave of lawsuits over the past decade as governments and others sought to hold drugmakers, wholesalers and pharmacies accountable for the opioid epidemic that started rising in the years after OxyContin hit the market in 1996."

Associated PressAssociated Press
·3M
Article

"The $7.4 billion will support opioid addiction treatment, prevention and recovery programs over the next 15 years."

ABC NewsABC News
·3M
Article

Articles (6)

Compare how different news outlets are covering this story.

FAQ

Dig deeper on this story with frequently asked questions.

The Sackler family will pay $1.5 billion, and Purdue Pharma will pay approximately $900 million in the first year.

The funds will be allocated to support addiction treatment, prevention, and recovery services across the U.S.

This settlement is one of the largest efforts to address the opioid epidemic, marking a unified endeavor to combat addiction and overdose across the U.S.

History

See how this story has evolved over time.

  • 3M
    Al Jazeera logo
    Washington Examiner logo
    ABC News logo
    3 articles